WILLS EYE RESEARCH PUBLICATIONS
FEBRUARY 2022
*A Wills Eye affiliation search function was used in PubMed to populate the list below. Any manuscripts published in February 2022 under a different affiliation and/or not present on PubMed was not included in this list.
CORNEA
Sajjadi Z, Baş Z, Shields CL. Hyperreflective band on anterior segment optical coherence tomography. Indian J Ophthalmol. 2022 Feb;70(2):361. doi: 10.4103/ijo.IJO_302_21. PMID: 35086197. https://pubmed.ncbi.nlm.nih.gov/35086197/
GENERAL OPHTHALMOLOGY
Justin GA, Miller SC, Tsou B, Li X, Purt B, Fliotsos MJ, Zhao J, Gardner SE, Legault GL, Yonekawa Y, Rapuano CJ, Woreta FA, Pelton RW. Ghost and Honorary Authorship in Ophthalmology: A Cross-Sectional Survey. Am J Ophthalmol. 2022 Feb 25:S0002-9394(22)00067-8. doi: 10.1016/j.ajo.2022.02.012. Epub ahead of print. PMID: 35227695. https://pubmed.ncbi.nlm.nih.gov/35227695/
GLAUCOMA
Gardiner SK, Kinast RM, Chen TC, Strouthidis NG, De Moraes CG, Nouri-Mahdavi K, Myers JS, Jeoung JW, Lind JT, Rhodes LA, Budenz DL, Mansberger SL. Clinicians' Use of Quantitative Information when Assessing the Rate of Structural Progression in Glaucoma. Ophthalmol Glaucoma. 2022 Feb 7:S2589-4196(22)00019-9. doi: 10.1016/j.ogla.2022.02.001. Epub ahead of print. PMID: 35144008. https://pubmed.ncbi.nlm.nih.gov/35144008/
Kader MA, Dabke SB, Shukla AG, Reddy V, Abdul Khadar SM, Maheshwari D, Ramakrishnan R. Pars plana Aurolab aqueous drainage implantation for refractory glaucoma: Outcome of a new modified technique. Indian J Ophthalmol. 2022 Mar;70(3):839-845. doi: 10.4103/ijo.IJO_1791_21. PMID: 35225526. https://pubmed.ncbi.nlm.nih.gov/35225526/
Kader MA, Pradhan A, Shukla AG, Maheswari D, Ramakrishnan R, Midya D. Lowering of intraocular pressure after phacoemulsification in primary open-angle and angle-closure glaucoma: Correlation with lens thickness. Indian J Ophthalmol. 2022 Feb;70(2):574-579. doi: 10.4103/ijo.IJO_1538_21. PMID: 35086240. https://pubmed.ncbi.nlm.nih.gov/35086240/
Shankar LG, Odayappan A, Shukla AG, C R V, Venkatesh R, Kavitha S. 0.1% Nepafenac Vs. 0.09% Bromfenac Eye Drops for Post Laser Peripheral Iridotomy Inflammation - A Randomised Controlled Trial. Ophthalmol Glaucoma. 2022 Feb 20:S2589-4196(22)00027-8. doi: 10.1016/j.ogla.2022.02.009. Epub ahead of print. PMID: 35196591. https://pubmed.ncbi.nlm.nih.gov/35196591/
Vishwaraj CR, Kavitha S, Venkatesh R, Shukla AG, Chandran P, Tripathi S. Neuroprotection in glaucoma. Indian J Ophthalmol. 2022 Feb;70(2):380-385. doi: 10.4103/ijo.IJO_1158_21. PMID: 35086201. https://pubmed.ncbi.nlm.nih.gov/35086201/
NEURO-OPHTHALMOLOGY
Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Mebrahtu S, Bergmann C, Wilken J, Gudesblatt M. Longitudinal assessment of the relationship between visual evoked potentials and cognitive performance in multiple sclerosis. Clin Neurophysiol. 2022 Feb 26;137:66-74. doi: 10.1016/j.clinph.2022.02.013. Epub ahead of print. PMID: 35279530. https://pubmed.ncbi.nlm.nih.gov/35279530/
OCULAR ONCOLOGY
Shields CL, Bas Z, Laiton A, Silva AMV, Sheikh A, Lally SE, Shields JA. Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact. Eye (Lond). 2022 Feb 25:1–8. doi: 10.1038/s41433-022-01980-0. Epub ahead of print. PMID: 35217824; PMCID: PMC8873344. https://pubmed.ncbi.nlm.nih.gov/35217824/
RETINA
Al-Moujahed A, Lin JH, Gagnon MR, Pulido J, Mruthyunjaya P, Jung JJ. Bilateral Serpiginous-Like Chorioretinitis Associated with Ciliochoroidal Melanoma: A Clinicopathologic Correlation. Retina. 2022 Feb 9. doi: 10.1097/IAE.0000000000003435. Epub ahead of print. PMID: 35174798. https://pubmed.ncbi.nlm.nih.gov/35174798/
Bowe T, Salabati M, Soares RR, Huang C, Singh RP, Khan MA, Williams BK Jr, Sridhar J, Chiang A, Cohen MN, Klufas MA, Gupta OP, Yonekawa Y, Xu D, Kuriyan AE. Racial Disparities in Enrollment and Participation in Diabetic Macular Edema Clinical Trials in the United States. Ophthalmol Retina. 2022 Feb 4:S2468-6530(22)00040-9. doi: 10.1016/j.oret.2022.01.018. Epub ahead of print. PMID: 35131526. https://pubmed.ncbi.nlm.nih.gov/35131526/
Huang D, Starr MR, Patel LG, Ammar M, Kaiser RS, Mehta S, Park C, Khan MA, Gupta O, Kuriyan AE, Yonekawa Y, Ho AC, Garg S, Cohen MN, Hsu J. Factors affecting retinal re-detachment following silicone oil removal for rhegmatogenous retinal detachments. Retina. 2022 Feb 4. doi: 10.1097/IAE.0000000000003445. Epub ahead of print. PMID: 35174811. https://pubmed.ncbi.nlm.nih.gov/35174811/
Patel SN, Garg SJ; Post-Injection Endophthalmitis Study Group. Reply. Ophthalmology. 2022 Feb 26:S0161-6420(22)00070-7. doi: 10.1016/j.ophtha.2022.01.018. Epub ahead of print. PMID: 35232583. https://pubmed.ncbi.nlm.nih.gov/35232583/
Shahlaee A, Woeller CF, Philp NJ, Kuriyan AE. Translational and clinical advancements in management of proliferative vitreoretinopathy. Curr Opin Ophthalmol. 2022 Feb 25. doi: 10.1097/ICU.0000000000000840. Epub ahead of print. PMID: 35220328. https://pubmed.ncbi.nlm.nih.gov/35220328/
Sharma A, Kumar N, Parachuri N, Regillo CD, Bandello F, Kuppermann BD. Retina: a unique subspecialty in the biosimilar landscape. Eye (Lond). 2022 Feb 21. doi: 10.1038/s41433-022-01984-w. Epub ahead of print. PMID: 35190669. https://pubmed.ncbi.nlm.nih.gov/35190669/
Soares RR. The evolving field of Big Data: understanding geographic information systems analysis and its transformative potential in ophthalmic research. Curr Opin Ophthalmol. 2022 Feb 25. doi: 10.1097/ICU.0000000000000839. Epub ahead of print. PMID: 35220329. https://pubmed.ncbi.nlm.nih.gov/35220329/
Soares RR, Huang C, Boucher N, Aggarwal N, Fernando R, Hinkle J, DeSimone J, Cai L, Patel SN, Xu D, Kuriyan AE, Yonekawa Y. Regional population mobility and outpatient retina visits in the United States during the COVID-19 pandemic. Retina. 2022 Feb 7. doi: 10.1097/IAE.0000000000003449. Epub ahead of print. PMID: 35174800. https://pubmed.ncbi.nlm.nih.gov/35174800/
Late additions to PubMed – Articles published in January 2022
Wong M, Frank JH, Shields CL. Non-small cell lung cancer with iris metastasis controlled with osimertinib and monthly intravitreal bevacizumab. Am J Ophthalmol Case Rep. 2022 Jan 20;25:101269. doi: 10.1016/j.ajoc.2022.101269. PMID: 35112017; PMCID: PMC8790597. https://pubmed.ncbi.nlm.nih.gov/35112017/
Sehgal A, Pulido JS, Mashayekhi A, Milman T, Deák GG. Diagnosing Vitreoretinal Lymphomas-An Analysis of the Sensitivity of Existing Tools. Cancers (Basel). 2022 Jan 25;14(3):598. doi: 10.3390/cancers14030598. PMID: 35158867; PMCID: PMC8833443. https://pubmed.ncbi.nlm.nih.gov/35158867/